Morgan Keegan Raises PT On HCP To $43
Morgan Keegan has raised the price target on HCP, Inc. (NYSE: HCP) from $40 to $43 and maintains its Outperform rating.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: HCP Morgan KeeganPrice Target Analyst Ratings